Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Consumer Cyclical Healthcare Technology Advertising Agencies Biotechnology Software - Application Cannabis
Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial... see more

Recent & Breaking News (TSX:WLLW)

Willow Biosciences Announces Commercial Scale Operational Update, CBGA Production Update and Corporate Update

PR Newswire September 21, 2021

Willow Biosciences Reports Second Quarter 2021 Results

PR Newswire August 9, 2021

Willow Biosciences Announces Expansion of its Commercial Operations Team and Development Portfolio, an Update on its Intellectual Property Position, and Formation of ESG Committee

PR Newswire July 20, 2021

Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigerol (CBG)

PR Newswire June 10, 2021

Willow Biosciences Announces Participation In Synbiobeta Panel Discussion

PR Newswire May 25, 2021

Willow Biosciences Added to NYSE-Listed Cannabis ETF "THCX"

PR Newswire May 18, 2021

Willow Biosciences Reports First Quarter 2021 Results, an Operational Update and the Addition of a New Board Member

Canada NewsWire May 7, 2021

Willow Biosciences Announces Annual General and Special Meeting Voting Results

Canada NewsWire April 28, 2021

Willow Biosciences Announces Ground-Breaking Scientific Data for Cannabigerol (CBG) on Human Skin

PR Newswire April 20, 2021

Willow Biosciences Announces Completion of its First Commercial Scale Fermentation Run

PR Newswire March 31, 2021

Willow Biosciences Reports Fourth Quarter and 2020 Year End Results and Operational Update

Canada NewsWire March 23, 2021

Willow Biosciences Provides Update on Acceleration of Expiry Date of Outstanding Warrants Issued Pursuant to October 2020 Unit Financing

Canada NewsWire March 3, 2021

Willow Biosciences Announces Exercise of Over-Allotment Option and Completion of Previously Announced Bought Deal Offering

Canada NewsWire February 19, 2021

IIROC Trade Resumption - WLLW

Canada NewsWire February 12, 2021

Willow Biosciences Announces Increase to Bought Deal Offering from $20.0 Million to $25.0 Million

GlobeNewswire February 11, 2021

Willow Biosciences Announces $20.0 Million Bought Deal Offering

GlobeNewswire February 11, 2021

IIROC Trading Halt - WLLW

Canada NewsWire February 11, 2021

Willow Biosciences Announces Acceleration of Expiry Date of Outstanding Warrants Issued Pursuant to October 2020 Unit Financing

Canada NewsWire January 25, 2021

Willow Biosciences Advances Its Work On THC; Plans To Launch In The Canadian Market

PR Newswire January 19, 2021

Willow Biosciences Provides Update on Cannabigerol Research Studies and Key Personnel Appointment

PR Newswire January 13, 2021